Skip to main content
PMC home page
Gut logoLink to Gut
. 1991 Dec;32(12):1433–1435. doi: 10.1136/gut.32.12.1433

Aetiology and natural history of primary sclerosing cholangitis--a decade of progress?

R W Chapman 1
PMCID: PMC1379237  PMID: 1773944

Full text

PDF
1433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aadland E., Schrumpf E., Fausa O., Elgjo K., Heilo A., Aakhus T., Gjone E. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol. 1987 Aug;22(6):655–664. doi: 10.3109/00365528709011139. [DOI] [PubMed] [Google Scholar]
  2. Bodenheimer H. C., Jr, LaRusso N. F., Thayer W. R., Jr, Charland C., Staples P. J., Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology. 1983 Mar-Apr;3(2):150–154. doi: 10.1002/hep.1840030203. [DOI] [PubMed] [Google Scholar]
  3. CAREY J. B. BILE ACIDS, CIRRHOSIS, AND HUMAN EVOLUTION. Gastroenterology. 1964 Apr;46:490–493. [PubMed] [Google Scholar]
  4. Chapman R. W., Arborgh B. A., Rhodes J. M., Summerfield J. A., Dick R., Scheuer P. J., Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980 Oct;21(10):870–877. doi: 10.1136/gut.21.10.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chapman R. W., Burroughs A. K., Bass N. M., Sherlock S. Long-standing asymptomatic primary sclerosing cholangitis: report of three cases. Dig Dis Sci. 1981 Sep;26(9):778–782. doi: 10.1007/BF01309608. [DOI] [PubMed] [Google Scholar]
  6. Chapman R. W., Kelly P. M., Heryet A., Jewell D. P., Fleming K. A. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut. 1988 Apr;29(4):422–427. doi: 10.1136/gut.29.4.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chapman R. W. Primary sclerosing cholangitis. J Hepatol. 1985;1(2):179–186. doi: 10.1016/s0168-8278(85)80765-0. [DOI] [PubMed] [Google Scholar]
  8. Chapman R. W., Varghese Z., Gaul R., Patel G., Kokinon N., Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut. 1983 Jan;24(1):38–41. doi: 10.1136/gut.24.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dew M. J., van Berge Henegouwen G. P., Huybregts A. W., Allan R. N. Hepatotoxic effect of bile acids in inflammatory bowel disease. Gastroenterology. 1980 Jun;78(6):1393–1401. [PubMed] [Google Scholar]
  10. Eade M. N., Brooke B. N. Portal bacteraemia in cases of ulcerative colitis submitted to colectomy. Lancet. 1969 May 17;1(7603):1008–1009. doi: 10.1016/s0140-6736(69)91802-9. [DOI] [PubMed] [Google Scholar]
  11. Helzberg J. H., Petersen J. M., Boyer J. L. Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology. 1987 Jun;92(6):1869–1875. doi: 10.1016/0016-5085(87)90618-4. [DOI] [PubMed] [Google Scholar]
  12. Holzbach R. T., Marsh M. E., Freedman M. R., Fazio V. W., Lavery I., Jagelman D. A. Portal vein bile acids in patients with severe inflammatory bowel disease. Gut. 1980 May;21(5):428–435. doi: 10.1136/gut.21.5.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lebovics E., Palmer M., Woo J., Schaffner F. Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients. Arch Intern Med. 1987 Apr;147(4):729–731. [PubMed] [Google Scholar]
  14. Lindor K. D., Wiesner R. H., Katzmann J. A., LaRusso N. F., Beaver S. J. Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci. 1987 Jul;32(7):720–725. doi: 10.1007/BF01296138. [DOI] [PubMed] [Google Scholar]
  15. Lindor K. D., Wiesner R. H., LaRusso N. F. Recent advances in the management of primary sclerosing cholangitis. Semin Liver Dis. 1987 Nov;7(4):322–327. doi: 10.1055/s-2008-1040588. [DOI] [PubMed] [Google Scholar]
  16. Ludwig J., Barham S. S., LaRusso N. F., Elveback L. R., Wiesner R. H., McCall J. T. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology. 1981 Nov-Dec;1(6):632–640. doi: 10.1002/hep.1840010612. [DOI] [PubMed] [Google Scholar]
  17. MISTILIS S. P. PERICHOLANGITIS AND ULCERATIVE COLITIS. I. PATHOLOGY, ETIOLOGY, AND PATHOGENESIS. Ann Intern Med. 1965 Jul;63:1–16. doi: 10.7326/0003-4819-63-1-1. [DOI] [PubMed] [Google Scholar]
  18. MISTILIS S. P., SKYRING A. P., GOULSTON S. J. PERICHOLANGITIS AND ULCERATIVE COLITIS. II. CLINICAL ASPECTS. Ann Intern Med. 1965 Jul;63:17–26. doi: 10.7326/0003-4819-63-1-17. [DOI] [PubMed] [Google Scholar]
  19. McFarlane I. G., Wojcicka B. M., Tsantoulas D. C., Portmann B. C., Eddleston A. L., Williams R. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases. Gastroenterology. 1979 Jun;76(6):1333–1340. [PubMed] [Google Scholar]
  20. Minuk G. Y., Rascanin N., Paul R. W., Lee P. W., Buchan K., Kelly J. K. Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol. 1987 Aug;5(1):8–13. doi: 10.1016/s0168-8278(87)80054-5. [DOI] [PubMed] [Google Scholar]
  21. Mir-Madjlessi S. H., Farmer R. G., Sivak M. V., Jr Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis: report of six cases and review of the literature. Dig Dis Sci. 1987 Feb;32(2):145–154. doi: 10.1007/BF01297102. [DOI] [PubMed] [Google Scholar]
  22. Olsson R., Hultén L. Concurrence of ulcerative colitis and chronic acitve hepatitis, Clinical courses and results of colectomy. Scand J Gastroenterol. 1975;10(3):331–335. [PubMed] [Google Scholar]
  23. Palmer K. R., Duerden B. I., Holdsworth C. D. Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut. 1980 Oct;21(10):851–854. doi: 10.1136/gut.21.10.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Porayko M. K., Wiesner R. H., LaRusso N. F., Ludwig J., MacCarty R. L., Steiner B. L., Twomey C. K., Zinsmeister A. R. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology. 1990 Jun;98(6):1594–1602. doi: 10.1016/0016-5085(90)91096-o. [DOI] [PubMed] [Google Scholar]
  25. Prochazka E. J., Terasaki P. I., Park M. S., Goldstein L. I., Busuttil R. W. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med. 1990 Jun 28;322(26):1842–1844. doi: 10.1056/NEJM199006283222603. [DOI] [PubMed] [Google Scholar]
  26. Quigley E. M., LaRusso N. F., Ludwig J., MacSween R. N., Birnie G. G., Watkinson G. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1983 Nov;85(5):1160–1165. [PubMed] [Google Scholar]
  27. Ritchie J. K., Allan R. N., Macartney J., Thompson H., Hawley P. R., Cooke W. T. Biliary tract carcinoma associated with ulcerative colitis. Q J Med. 1974 Apr;43(170):263–279. [PubMed] [Google Scholar]
  28. Schrumpf E., Fausa O., Førre O., Dobloug J. H., Ritland S., Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol. 1982 Mar;17(2):187–191. doi: 10.3109/00365528209182038. [DOI] [PubMed] [Google Scholar]
  29. Schrumpf E., Fausa O., Kolmannskog F., Elgjo K., Ritland S., Gjone E. Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand J Gastroenterol. 1982 Jan;17(1):33–39. doi: 10.3109/00365528209181041. [DOI] [PubMed] [Google Scholar]
  30. Senaldi G., Donaldson P. T., Magrin S., Farrant J. M., Alexander G. J., Vergani D., Williams R. Activation of the complement system in primary sclerosing cholangitis. Gastroenterology. 1989 Dec;97(6):1430–1434. doi: 10.1016/0016-5085(89)90386-7. [DOI] [PubMed] [Google Scholar]
  31. Shepherd H. A., Selby W. S., Chapman R. W., Nolan D., Barbatis C., McGee J. O., Jewell D. P. Ulcerative colitis and persistent liver dysfunction. Q J Med. 1983 Autumn;52(208):503–513. [PubMed] [Google Scholar]
  32. Siegel J. H., Barnes S., Morris J. S. Bile acids in liver disease associated with inflammatory bowel disease. Digestion. 1977;15(6):469–481. doi: 10.1159/000198038. [DOI] [PubMed] [Google Scholar]
  33. Snook J. A., Chapman R. W., Fleming K., Jewell D. P. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 1989 Apr;76(1):30–33. [PMC free article] [PubMed] [Google Scholar]
  34. Warren K. W., Athanassiades S., Monge J. I. Primary sclerosing cholangitis. A study of forty-two cases. Am J Surg. 1966 Jan;111(1):23–38. doi: 10.1016/0002-9610(66)90339-4. [DOI] [PubMed] [Google Scholar]
  35. Wee A., Ludwig J., Coffey R. J., Jr, LaRusso N. F., Wiesner R. H. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol. 1985 Jul;16(7):719–726. doi: 10.1016/s0046-8177(85)80158-1. [DOI] [PubMed] [Google Scholar]
  36. Wee A., Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med. 1985 May;102(5):581–587. doi: 10.7326/0003-4819-102-5-581. [DOI] [PubMed] [Google Scholar]
  37. Whiteside T. L., Lasky S., Si L., Van Thiel D. H. Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology. 1985 May-Jun;5(3):468–474. doi: 10.1002/hep.1840050321. [DOI] [PubMed] [Google Scholar]
  38. Wiesner R. H., Grambsch P. M., Dickson E. R., Ludwig J., MacCarty R. L., Hunter E. B., Fleming T. R., Fisher L. D., Beaver S. J., LaRusso N. F. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 1989 Oct;10(4):430–436. doi: 10.1002/hep.1840100406. [DOI] [PubMed] [Google Scholar]
  39. Wiesner R. H., LaRusso N. F. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology. 1980 Aug;79(2):200–206. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES